{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T06:25:09Z","timestamp":1782368709120,"version":"3.54.5"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1016\/j.jaad.2005.09.010","type":"journal-article","created":{"date-parts":[[2006,9,28]],"date-time":"2006-09-28T08:34:42Z","timestamp":1159432482000},"page":"632-636","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"title":["The use of methotrexate alone or in combination with low doses of oral corticosteroids in the treatment of alopecia totalis or universalis"],"prefix":"10.1016","volume":"55","author":[{"given":"Pascal","family":"Joly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2005.09.010_bib1","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1067\/mjd.2000.103909","article-title":"Alopecia areata update","volume":"42","author":"Madani","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2005.09.010_bib2","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1046\/j.1365-2133.2003.05535.x","article-title":"Guidelines for the management of alopecia areata","volume":"149","author":"McDonald Hull","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.09.010_bib3","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0190-9622(99)70195-7","article-title":"Alopecia areata investigational assessment guidelines: National Alopecia Areata Foundation","volume":"40","author":"Olsen","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2005.09.010_bib4","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1001\/archderm.1992.01680210045005","article-title":"Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata","volume":"128","author":"Olsen","year":"1992","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2005.09.010_bib5","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2174\/1381612013398266","article-title":"Current and potential agents for the treatment of alopecia areata","volume":"7","author":"Freyschmidt-Paul","year":"2001","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jaad.2005.09.010_bib6","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1067\/mjd.2003.423","article-title":"Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis\/universalis","volume":"49","author":"Tosti","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2005.09.010_bib7","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1046\/j.1365-2133.2002.500210.x","article-title":"Is topical tacrolimus effective in alopecia areata universalis?","volume":"147","author":"Feldmann","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.09.010_bib8","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0738-081X(02)00272-9","article-title":"Topical immunotherapy: unapproved uses, dosages, or indications","volume":"20","author":"Higgins","year":"2002","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaad.2005.09.010_bib9","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0190-9622(98)70048-9","article-title":"Efficacy of topical sensitizers in the treatment of alopecia areata","volume":"39","author":"Rokhsar","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2005.09.010_bib10","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1080\/00015550252948202","article-title":"Systemic immunotherapy with topical dinitrochlorobenzene as additional treatment of alopecia areata","volume":"82","author":"Yoshizawa","year":"2002","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2005.09.010_bib11","first-page":"327","article-title":"Diphencyprone immunotherapy alters anti-hair follicle antibody status in patients with alopecia areata","volume":"12","author":"Tobin","year":"2002","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2005.09.010_bib12","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1067\/mjd.2001.110060","article-title":"The PUVA-turban as a new option of applying a dilute psoralen solution selectively to the scalp of patients with alopecia areata","volume":"44","author":"Behrens-Williams","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2005.09.010_bib13","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1365-2133.1995.tb06925.x","article-title":"PUVA treatment of alopecia areata partialis, totalis and universalis: audit of 10 years' experience at St John's Institute of Dermatology","volume":"133","author":"Taylor","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.09.010_bib14","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000051642","article-title":"High-dose pulse corticosteroid therapy in the treatment of severe alopecia areata","volume":"202","author":"Seiter","year":"2001","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2005.09.010_bib15","first-page":"326","article-title":"Intravenous pulse methylprednisolone therapy for severe alopecia areata: an open study of 66 patients","volume":"130","author":"Assouly","year":"2003","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.jaad.2005.09.010_bib16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-4362.1996.tb03281.x","article-title":"Pulsed administration of corticosteroids in the treatment of alopecia areata","volume":"35","author":"Sharma","year":"1996","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2005.09.010_bib17","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1056\/NEJMoa021359","article-title":"Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis","volume":"349","author":"Heydendael","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2005.09.010_bib18","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1067\/mjd.2003.137","article-title":"Experience with low-dose methotrexate for the treatment of eczema in the elderly","volume":"48","author":"Shaffrali","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2005.09.010_bib19","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1001\/archderm.138.9.1255","article-title":"Treatment of bullous pemphigoid by low-dose methotrexate associated with short-term potent topical steroids: an open prospective study of 18 cases","volume":"138","author":"Dereure","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2005.09.010_bib20","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1056\/NEJM199909233411307","article-title":"Treatment of hair loss","volume":"341","author":"Price","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2005.09.010_bib21","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1046\/j.1365-2133.2000.03783.x","article-title":"Topical photodynamic therapy with 5-aminolaevulinic acid does not induce hair regrowth in patients with extensive alopecia areata","volume":"143","author":"Bissonnette","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.09.010_bib22","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0010-440X(91)90045-E","article-title":"Lifetime prevalence of psychiatric disorders in patients with alopecia area","volume":"32","author":"Colon","year":"1991","journal-title":"Compr Psychiatry"},{"key":"10.1016\/j.jaad.2005.09.010_bib23","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1365-4632.2004.02028.x","article-title":"The role of psychological factors in alopecia areata and the impact of the disease on the quality of life","volume":"43","author":"Gulec","year":"2004","journal-title":"Int J Dermtol"},{"key":"10.1016\/j.jaad.2005.09.010_bib24","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/00004583-199705000-00019","article-title":"Children with alopecia areata: psychiatric symptomatology and life events","volume":"36","author":"Liakopoulou","year":"1997","journal-title":"J Am Acad Child Adolesc Psychiatry"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962205030008?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962205030008?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:03:52Z","timestamp":1759269832000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962205030008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S0190962205030008"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2005.09.010","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The use of methotrexate alone or in combination with low doses of oral corticosteroids in the treatment of alopecia totalis or universalis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2005.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}